| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8280416 | Journal of the Neurological Sciences | 2012 | 5 Pages |
Abstract
The present study suggests that GSK-3β inhibitor would be a novel promising therapeutic strategy in ALS; however neuroprotective effect of GSK-3β inhibitor may be reduced via extrinsic apoptosis or non-neuronal patho-mechanism in late-stage of disease.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Suk-Won Ahn, Jee-Eun Kim, Kyung Seok Park, Won-Jun Choi, Yoon-Ho Hong, Sung-Min Kim, Seung Hyun Kim, Kwang-Woo Lee, Jung-Joon Sung,